Zymeworks Inc.

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. Show More...

Website https://www.zymeworks.com
Sector Healthcare
Industry Biotechnology
Last Quote 11.43 USD
Last Updated 30-05-2025
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2014-12	2015-12	2016-12	2017-12	2018-12	2019-12	TTM
Earnings Per Share USD	-0.65	-0.97	-1.72	-0.64	-1.26	-3.83	-4.04
Dividends USD
Payout Ratio % *
Shares Mil	20.0	20.0	20.0	21.0	29.0	38.0	42.0
Book Value Per Share * USD				3.25	5.31	7.82	11.47
Free Cash Flow Per Share * USD				-2.08	0.35	-0.21
Return on Assets %		-82.81	-58.83	-9.67	-19.43	-47.48	-37.25
Financial Leverage (Average)		1.27	10.44	1.13	1.35	1.5	1.22
Return on Equity %		-105.1	-252.99	-17.42	-24.62	-68.25	-47.06
Return on Invested Capital %		-106.3	-187.87	-16.65	-25.84	-69.92	-47.78
Interest Coverage			-39.93	-10.17	-206.14
Current Ratio		3.64	2.81	6.3	6.82	3.78	6.92
Quick Ratio		3.59	2.69	6.15	6.72	3.65	6.81
Debt/Equity			0.49			0.02	0.010

Zymeworks Inc.

Interest Coverage